- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Minimal Residual Disease
Explore clinical trials studying Minimal Residual Disease. Study availability and eligibility vary by location and protocol.
48 public trials
20 recruiting studies
Minimal Residual Disease trial results
NCT06287814
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +17 more
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
NCT06287723
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
- Locations
-
- CHU de Montpellier Montpellier, France
- Institu régional du Cancer de Montpellier (ICM) Montpellier, France
NCT07136077
- Conditions
- Adjuvant Chemotherapy, Colonic Diseases, Colorectal Cancer, +18 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05735717
- Conditions
- AML, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
- Locations
-
- University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
- Conditions
- Immunotherapy, Lung Diseases, Lung Neoplasms, +11 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Recruiting
Caris Biorepository Research Protocol
NCT01499394
- Conditions
- Cancer, Early Detection of Cancer, Minimal Residual Disease, +5 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Southwest Medical Imaging Scottsdale, Arizona, United States
- St. Bernards Medical Center Jonesboro, Arkansas, United States
- CARTI Cancer Center Little Rock, Arkansas, United States
NCT06287749
- Conditions
- CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
NCT05959720
- Conditions
- Acute Lymphoid Leukemia, Chemotherapeutic Toxicity, Gene Abnormality, +16 more
- Locations
-
- Instituto do Cancer do Estado de Sao Paulo São Paulo, Brazil